Regulatory

Catalyst can now address stemless anatomic and reverse TSA, the two fastest growing segments of the shoulder replacement market.

The notice relates to a higher than expected risk of fracture in the device's plastic component, as early as 3 to 4 years post-implantation.

iTotal PS patient-specific implants fit the size and shape of each patient's knee, and provide stability throughout the full range of motion.

The SpaceFlex Shoulder is now available in the U.S., joining G21's hip and knee modular spacer mold systems.

The application for the two-component patellofemoral implant is slated for filing in 2021, followed by launch in 2022.

Easytech is the only primary peripheral fitting anatomic stemless shoulder on the market.

Additive Orthopaedics received an approval order for its Humanitarian Device Exemption application for treatment of avascular necrosis.

MyHip Planner and MyHip Verifier are personalized solutions used in primary total hip replacement.

The Smart SPACE digital platform features novel orthopedic technology and a pipeline of landscape-changing applications for the shoulder.

With this FDA clearance, BioPoly technology is available for the first time in the U.S.